梅雁吉祥(600868.SH):持股7.14%的廣東能潤提議公司選聘立信為2020年度審計機構
格隆匯3月12日丨梅雁吉祥(600868.SH)公佈,為了公司經營發展需要和年度審計工作安排,持股7.14%的股東廣東能潤資產管理有限公司以臨時提案方式提議公司2020年度不再續聘廣東正中珠江會計師事務所(特殊普通合夥)為公司的審計機構。廣東正中珠江會計師事務所對公司擬變更會計師事務所事項無異議。
並提議公司選聘立信會計師事務所(特殊普通合夥)為公司2020年度會計審計機構及內部控制審計機構,聘期一年,期滿可以續聘。並提請股東大會審議及授權公司董事會根據審計工作量及公允合理的定價原則確定其年度審計費用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.